菌血症
荟萃分析
肺炎
医学
重症监护医学
社区获得性肺炎
环境卫生
内科学
微生物学
生物
抗生素
作者
Shanshan Wu,Lin Chen,Xiaoyan zhang,Jiali Fan,Fajuan Tang,Dongqiong Xiao
标识
DOI:10.1016/j.ijid.2024.107312
摘要
BACKGROUND: Bacteremia represents a significant complication in patients with community-acquired pneumonia (CAP). Nonetheless, there is currently a dearth of systematic research that determines the precise prevalence and risk factors of bacteremia in CAP patients. METHODS: PubMed, Cochrane Library, Embase, and Web of Science databases were searched for published studies on the prevalence or risk factors for CAP with bacteremia up to April 21, 2024. The NOS scale was utilized to appraise the study quality, and the META process was carried out in R language. RESULTS: 58,342 CAP patients were enrolled in 22 studies. Of these patients, 29,610 underwent blood culture tests, and 2332 patients had positive blood culture results. Meta-analysis pooled results showed that the incidence of bacteremia was 5.1% (95% CI: 3.6-6.8%) in CAP patients. The prevalence of co-bacteremia was 3.1% (95% CI: 1.5-5.1%) in minors and 6.9% (95% CI: 5.2%-8.8%) in adults. The most common pathogens of CAP were Streptococcus pneumoniae, Staphylococcus aureus. In addition, a summary of the original studies found that the risk factors for bacteremia in CAP patients were diverse and varied. CONCLUSIONS: The incidence of bacteremia in CAP patients warrants significant attention. There is a pressing need to establish more specific bacterial screening protocols.
科研通智能强力驱动
Strongly Powered by AbleSci AI